US Broker Ratings

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a 109.72% Potential Upside in the Biotech Sector

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative RNA medicines platform, PRISM. Based in Singapore, the company is at the forefront of..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unlocking a Potential 180% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) presents a compelling opportunity for investors in the biotechnology sector, with a potential upside of 180.70% based on the average target price of $45.92. This..

Catalyst Pharmaceuticals (CPRX): Analysts See 66% Upside for This Biotech Innovator

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is catching the attention of investors with its promising potential upside. This commercial-stage biopharmaceutical company, headquartered in Coral Gables, Florida, focuses on developing and commercializing..

CONMED Corporation (CNMD) Stock Analysis: Navigating a 12.21% Potential Upside in the Medical Devices Sector

CONMED Corporation (NYSE: CNMD) stands out in the healthcare sector with its innovative contributions to medical devices, focusing on surgical procedures and orthopedic solutions. With a robust market capitalization of..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a 35% Potential Upside in Healthcare Innovations

Omnicell, Inc. (OMCL), a key player in the healthcare sector, is drawing investor attention with its innovative medication management solutions and a promising potential upside of 35%. With a market..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Bold Bet with 262.95% Potential Upside

For investors keen on high-risk, high-reward opportunities, Janux Therapeutics, Inc. (NASDAQ: JANX) might be a compelling consideration. With a staggering potential upside of 262.95%, this clinical-stage biopharmaceutical company is generating..

MiMedx Group, Inc (MDXG) Stock Analysis: Healthcare Innovator with 71.83% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG), a pioneering entity in the biotechnology sector, is capturing investor attention with its innovative medical solutions and an enticing potential upside of 71.83%. Headquartered in..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 48% Upside in Synthetic DNA Solutions

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing investor attention with a noteworthy potential upside of 48.31%. With a..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO) is catching the attention of savvy investors looking for opportunities in the healthcare sector. With a current market capitalization of $1.28 billion, this U.S.-based medical devices..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Healthcare Contender with 53.10% Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is making waves in the healthcare sector as a dynamic player within the Drug Manufacturers – Specialty & Generic industry. With a robust market capitalization..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 60.22% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare sector, is garnering significant attention from investors due to its innovative approach in health information services and its intriguing..

GRAIL, Inc. (GRAL) Stock Analysis: A Healthcare Innovator with a 23.51% Upside Potential

GRAIL, Inc. (GRAL), a dynamic player in the healthcare sector, is making waves with its innovative approach to cancer diagnostics and research. Headquartered in Menlo Park, California, GRAIL specializes in..

Kestra Medical Technologies (KMTS): A 66% Potential Upside Amidst Rapid Revenue Growth

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a trailblazer in the healthcare sector specializing in medical instruments and supplies, is garnering attention from investors with its substantial growth potential. This U.S.-based..

agilon health, inc. (AGL) Stock Analysis: Unpacking the 21% Potential Upside in Healthcare Investment

agilon health, inc. (NYSE: AGL) operates in the dynamic healthcare sector, specifically within the medical care facilities industry. With its focus on providing comprehensive healthcare services to seniors through primary..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 125% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a dynamic player in the healthcare sector, is turning heads with a potential upside of 125.30% according to analyst ratings. With a market capitalization of..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 100% Upside Potential in Biotechnology

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently making waves among investors with its compelling growth potential and strategic collaborations. Headquartered in Burlingame, California, Innoviva..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech with a 93% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology firm, is garnering significant attention from investors due to its promising portfolio of immunotherapies and an impressive potential upside of 93.03%. Specializing..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 162% Potential Upside Amidst Market Challenges

Opko Health, Inc. (NASDAQ: OPK) is a prominent player within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $1.1 billion, Opko Health operates..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Uncovering a 28.89% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, has attracted significant investor interest due to its promising growth metrics and robust market presence. Specializing in..

89bio, Inc. (ETNB) Stock Analysis: Exploring a 232% Potential Upside in Biotechnology

89bio, Inc. (NASDAQ: ETNB) is making waves in the biotechnology sector with its promising pipeline and compelling financial metrics. This clinical-stage biopharmaceutical company, headquartered in San Francisco, is focused on..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds